These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 32953881)
1. Coexpression Network Analysis Identifies a Novel Nine-RNA Signature to Improve Prognostic Prediction for Prostate Cancer Patients. Cai J; Chen Z; Chen X; Huang H; Lin X; Miao B Biomed Res Int; 2020; 2020():4264291. PubMed ID: 32953881 [TBL] [Abstract][Full Text] [Related]
2. Five lncRNAs Associated With Prostate Cancer Prognosis Identified by Coexpression Network Analysis. Gong X; Ning B Technol Cancer Res Treat; 2020; 19():1533033820963578. PubMed ID: 33084528 [TBL] [Abstract][Full Text] [Related]
3. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network. Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658 [TBL] [Abstract][Full Text] [Related]
4. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer. Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783 [TBL] [Abstract][Full Text] [Related]
5. Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients. Cai J; Yang F; Chen X; Huang H; Miao B Pharmgenomics Pers Med; 2021; 14():797-811. PubMed ID: 34285549 [TBL] [Abstract][Full Text] [Related]
6. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma. Wang P; Zeng Z; Shen X; Tian X; Ye Q DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510 [TBL] [Abstract][Full Text] [Related]
7. Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients. Bai Z; Li H; Li C; Sheng C; Zhao X Medicine (Baltimore); 2020 Oct; 99(40):e21503. PubMed ID: 33019382 [TBL] [Abstract][Full Text] [Related]
8. Expression status and prognostic value of autophagy-related lncRNAs in prostate cancer. Chen G; Qin X; Wang Y; Gao B; Ling M; Yin W; Li Y; Pan B Cell Cycle; 2022 Aug; 21(16):1684-1696. PubMed ID: 35414328 [TBL] [Abstract][Full Text] [Related]
9. Identification of potential autophagy-associated lncRNA in prostate cancer. Li J; Du H; Chen W; Qiu M; He P; Ma Z Aging (Albany NY); 2021 May; 13(9):13153-13165. PubMed ID: 33971627 [TBL] [Abstract][Full Text] [Related]
10. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients. Huang H; Xu S; Chen A; Li F; Wu J; Tu X; Hu K Anal Cell Pathol (Amst); 2021; 2021():6697407. PubMed ID: 33833937 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer. Zhang X; Jiang Y; Xie Y; Leng X; Song F DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786 [TBL] [Abstract][Full Text] [Related]
12. LASSO‑based Cox‑PH model identifies an 11‑lncRNA signature for prognosis prediction in gastric cancer. Zhang Y; Li H; Zhang W; Che Y; Bai W; Huang G Mol Med Rep; 2018 Dec; 18(6):5579-5593. PubMed ID: 30365077 [TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma. Zhao J; Wang L; Wei B Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843 [TBL] [Abstract][Full Text] [Related]
14. Molecular network-based identification of competing endogenous RNAs and mRNA signatures that predict survival in prostate cancer. Xu N; Wu YP; Yin HB; Xue XY; Gou X J Transl Med; 2018 Oct; 16(1):274. PubMed ID: 30286759 [TBL] [Abstract][Full Text] [Related]
15. Identification of RBM15 as a prognostic biomarker in prostate cancer involving the regulation of prognostic m6A-related lncRNAs. Hu B; Lin D; Liu Z; Chen R; Liu J; Wu Y; Wang T Eur J Med Res; 2024 Aug; 29(1):411. PubMed ID: 39118157 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer. Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319 [TBL] [Abstract][Full Text] [Related]
17. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs. Zhao Q; Fan C BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053 [TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer. Yao Y; Zhang T; Qi L; Zhou C; Wei J; Feng F; Liu R; Sun C J Cell Mol Med; 2019 Dec; 23(12):8410-8419. PubMed ID: 31613058 [TBL] [Abstract][Full Text] [Related]
19. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma. Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618 [TBL] [Abstract][Full Text] [Related]
20. Screening of Significant Biomarkers Related to Prognosis of Cervical Cancer and Functional Study Based on lncRNA-associated ceRNA Regulatory Network. Ding H; Zhang L; Zhang C; Song J; Jiang Y Comb Chem High Throughput Screen; 2021; 24(3):472-482. PubMed ID: 32729415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]